MP48-05 NEOADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH UPPER TRACT UROTHELIAL CANCER: ONCOLOGIC OUTCOMES FROM A MULTICENTER STUDY

Nico C. Grossmann,Benjamin Pradere,David DAndrea,Victor M. Schuettfort,Keiichiro Mori,Paweł Rajwa,Fahad Quhal,Ekaterina Laukhtina,Satoshi Katayama,Christian D. Fankhauser,Evanguelos Xylinas,Vitaly Margulis,Alberto Briganti,Pierre I. Karakiewicz,Shahrokh F. Shariat

MP48-05 NEOADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH UPPER TRACT UROTHELIAL CANCER: ONCOLOGIC OUTCOMES FROM A MULTICENTER STUDY

2021

Nico C. Grossmann
Benjamin Pradere
David DAndrea
Victor M. Schuettfort
Keiichiro Mori
Paweł Rajwa
Fahad Quhal
Ekaterina Laukhtina
Satoshi Katayama
Christian D. Fankhauser
Evanguelos Xylinas
Vitaly Margulis
Alberto Briganti
Pierre I. Karakiewicz
Shahrokh F. Shariat

INTRODUCTION AND OBJECTIVE:The highest incidence of upper tract urothelial carcinoma (UTUC) is between 70-90 years of age and neoadjuvant chemotherapy (NAC) before radical nephroureterectomy (RNU) ...

Keywords:

Incidence (epidemiology)
urothelial carcinoma
Medicine
Chemotherapy
multicenter study
upper tract
Urology
urothelial cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations